Syros Pharmaceuticals, Inc. - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SYRS
Syros Pharmaceuticals (SYRS) is currently restructuring its development pipeline and aggressively conserving capital following a series of setbacks. The EBITDA reflects this process, where the indicator determines the magnitude of the metric. The company previously developed innovative methods for controlling gene transcription. Today, business success relies on its patent portfolio and tamibarotene trials for leukemia.
Ringkesan rincian data analitis Syros Pharmaceuticals, Inc. (SYRS)
- nilai saham lan prakiraan konsensus rega:
- rincian nilai pasar emiten:
- informasi kapitalisasi buku:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Syros Pharmaceuticals|SYRS - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Syros Pharmaceuticals Inc.|SYRS - Utang perusahaan|Utang marang nilai buku Syros Pharmaceuticals|SYRS - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Syros Pharmaceuticals|Indikator likuiditas cepet syros.com
- informasi bathi lan kelipatan valuasi:
SYRS - Bathi resik|Bathi resik sing dikarepake Syros Pharmaceuticals|SYRS - Koefisien rega marang bathi|Pangali Forward P/E syros.com|SYRS - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Syros Pharmaceuticals|SYRS - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Syros Pharmaceuticals|SYRS - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan syros.com|SYRS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Syros Pharmaceuticals
Analisis kabeh metrik perusahaan:SYRS - Syros Pharmaceuticals, Inc
The complexity of reproducing the biotechnological processes of Syros Pharmaceuticals (SYRS) and its patent shield make operational efficiency a key indicator of business viability. By analyzing the EBITDA history, an investor can see the net cash flow from operating activities without the influence of debt load, which allows for the separation of fundamental capitalization growth from market speculation and prevents overpaying for the asset.
Karo sapa Syros Pharmaceuticals saingan
Pendapatan operasional sadurunge ngurangi amortisasi Tempus (TEM)|QGEN: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi IONS (ionispharma.com)|Repligen (RGEN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi RNA (Avidity Biosciences Inc)|CRSP (CRISPR Therapeutics Corp) - Bathi operasional EBITDA|WGS: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA RARE|Bathi operasional EBITDA beamtx.com (BEAM)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sarepta SRPT|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi TWST|TXG - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Intellia Corp (NTLA) - Bathi operasional sadurunge ngurangi amortisasi|STOK: Bathi operasional EBITDA|biolifesolutions.com (BLFS) - Bathi operasional EBITDA|WVE (Wave Life Sciences Ltd.) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Maze Therapeutics, Inc. (MAZE)|Bathi operasional EBITDA SION|PRME - Bathi sadurunge bunga, pajak, lan amortisasi|Taysha Gene Therapies - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA uniqure.com QURE|MGTX: Bathi operasional sadurunge ngurangi amortisasi|REGENXBIO Inc - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|SLDB: Bathi operasional EBITDA|OCGN - Pendapatan operasional sadurunge ngurangi amortisasi|PACB (Pacific Biosciences) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi benitec.com (BNTC)|Bathi operasional EBITDA DSGN|Bathi operasional EBITDA Rocket Pharma (RCKT)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi 4D Molecular Therapeutics Inc FDMT|Lexeo Therapeutics Inc. - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|KRRO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi editasmedicine.com EDIT|Silence Therapeutics plc (SLN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|PRQR - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi CDXS|Bathi sadurunge bunga, pajak, lan amortisasi Sangamo BioSciences SGMO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Nautilus Biotechnology (NAUT)|MGX (metagenomi.co) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Precision BioSciences, Inc. DTIL|Pendapatan operasional sadurunge ngurangi amortisasi Generation Bio Co (GBIO)|Boundless Bio, Inc - Bathi operasional EBITDA|XCUR (Exicure, Inc.) - Bathi operasional sadurunge amortisasi|imunon.com (IMNN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi PHIO|MBIO (Mustang Bio Inc) - Bathi operasional EBITDA|Bathi operasional EBITDA TransCode|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Bionano Genomics, Inc. (BNGO)|Pendapatan operasional sadurunge ngurangi amortisasi Applied DNA Corp|bluebird bio, Inc. - Bathi operasional sadurunge ngurangi amortisasi|ImmunoPrecise Antibodies Ltd (IPA) - Bathi sadurunge bunga, pajak, lan amortisasi|OMGA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi OMIC (Singular Genomics Systems, Inc.)|Regulus Therapeutics Inc (RGLS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Telesis Bio, Inc (TBIO)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TRACON Pharmaceuticals|unitybiotechnology.com (UBX) - Pendapatan operasional sadurunge ngurangi amortisasi
